EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,847,476 | +194.2% | 356,380 | +220.3% | 0.00% | – |
| Q2 2023 | $967,892 | +733.1% | 111,252 | +181.5% | 0.00% | – |
| Q1 2023 | $116,177 | -55.9% | 39,516 | -47.5% | 0.00% | – |
| Q4 2022 | $263,428 | -69.4% | 75,265 | -30.8% | 0.00% | – |
| Q3 2022 | $860,000 | -33.4% | 108,781 | -33.7% | 0.00% | – |
| Q2 2022 | $1,291,000 | -42.7% | 164,100 | -11.5% | 0.00% | – |
| Q1 2022 | $2,253,000 | -21.1% | 185,400 | -20.5% | 0.00% | – |
| Q4 2021 | $2,854,000 | +146.0% | 233,200 | +109.5% | 0.00% | – |
| Q3 2021 | $1,160,000 | +26.0% | 111,300 | +8.6% | 0.00% | – |
| Q2 2021 | $921,000 | -29.0% | 102,500 | -19.8% | 0.00% | – |
| Q1 2021 | $1,297,000 | – | 127,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |